Partial obstruction of the left ureter was created in 2-day-old rats and released 2 days later. The effects were studied after 1, 2, 3 or 6 weeks. The obstruction resulted in prominent hydronephrosis, but the pelvic volume returned to normal already within 1 week after the release operation. In most of the previously obstructed kidneys there were small regions with moderately widened convoluted tubules and collecting ducts and minor areas with mild chronic pyelonephritis; these lesions were similar after 1 week as after 2–6 weeks, indicating that they were permanent. Judging from the parenchymal weight difference between the right and left kidney, there was slight reduction on the previously obstructed side at the 3rd week, balanced by hypertrophy on the contralateral side. At the 6th week the parenchymal weight reduction was no longer apparent but there was still evidence of contralateral hypertrophy. Thus, early release of the partial ureteric obstruction prevented persistent ipsilateral parenchymal weight reduction, without ensuring healing of the tissue lesions. The catch-up of parenchymal weight is probably due to the fact that the release was performed before the end of the period of postnatal nephron differentiation. Interference with this period seems to be the main cause of parenchymal weight reduction in permanent neonatal partial ureteric obstruction.

Keywords:
Experimental hydronephrosis, Newborn rats, Partial ureteric obstruction, Release of obstruction, Renal recovery, Morphology
This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.